ClinicalTrials.gg
Status unknownNCT02550951Updated Sep 16, 2015

Utility of MR Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy

An interventional study of lymphangiography in Lymphedema, sponsored by Seoul National University Hospital. Status unknown at 1 site in South Korea. Open to participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-09-16.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Sep 2015), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Non-randomized
Ages
20 Years and older
Sex
All
01

Study summary

Its usefulness in implementing magnetic resonance angiography for postoperative follow-up of lymph lymphedema should try to evaluate and compare lymphoscintigraphy.

Read the detailed description

Surgical methods include " surgical procedure to make a good lymphatic drain 'and' surgical resection with lymph tissue swelling , significant that two of lymphedema .In recent years, began receiving the spotlight this former method using micro-surgery , inde essential that in order to increase the success rate of these micro-surgery accurately assess the structural abnormalities of preoperative lymphatic and establishing the surgical plan , the primary diagnostic imaging examination of existing lymphedema Since the nuclear medicine examination as to obtain an accurate anatomical information it is also ideal for imaging in the preoperative assessment of lymphedema is precisely that you can not .

In contrast magnetic resonance lymphangiography recently developed a new magnetic resonance imaging techniques that many advantages in precision assessment of lymphedema patients.

First, there are high spatial resolution magnetic resonance lymphangiography through the lymphatic vessels to obtain the correct anatomical information .

Second, magnetic resonance lymphangiography is provide not only information about the functional status of the lymphatic anatomical information .

Third, the magnetic resonance lymphangiography minimally invasive techniques , without exposure to radiation , is relatively easy and safe , that there is a great advantage of being able to diagnose the structural and functional at the same time or later in lymphatic vessels.

The magnetic resonance lymphangiography via the lymphatic advantage given also helps to establish a specific treatment plan , as well as accurate preoperative diagnosis of lymphedema that may contribute to enhance the success of micro-surgery.

02

Conditions studied

  • Lymphedema

Browse trials for

03

In context

Lymphedema

569 studies on the registry are indexed under Lymphedema; 136 are open to participants now.

This study's enrollment of 7 is below the median of 50 across 407 interventional studies indexed under Lymphedema.

Browse Lymphedema studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,897 studies on the registry; 273 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 20 years of age
  • Patients underwent preoperative and receive magnetic resonance lymphangiography and Lymphoscintigraphy At the postoperative 3 months

Exclusion criteria

Exclusion Criteria:

  • Patients with a history of adverse effects on magnetic resonance contrast agents
  • Patients with a Decreased renal function(Glomerular filtration rate \<30 mL / min)
  • Other, maternity, patients with a pacemaker or a cochlear
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
7 participants (actual)

Study arms

  • Experimental
    pre-operation Lymphedema

    before magnetic resonance imaging(MRI), GADOVIST PFS \[Bayer Korea\] 7.5mL and local anesthetics 0.5m L mixed. and then 24 gauge needle using about 1 mL by the first , and second , the third the space between the toes intradermal injection , and then about 1-2 minutes , and massage the injection site, and Acquiring an image(coronal T1-weighted three-dimensional gradient-echo sequence) of the foot from a range including up to the pelvis from the comparison with lymphoscintigraphy

    Procedure: lymphangiography

  • Experimental
    post-operation Lymphedema

    before magnetic resonance imaging(MRI), GADOVIST PFS \[Bayer Korea\] 7.5mL and local anesthetics 0.5m L mixed. and then 24 gauge needle using about 1 mL by the first , and second , the third the space between the toes intradermal injection , and then about 1-2 minutes , and massage the injection site, and Acquiring an image(coronal T1-weighted three-dimensional gradient-echo sequence) of the foot from a range including up to the pelvis from the comparison with lymphoscintigraphy

    Procedure: lymphangiography

Interventions

  • Procedurelymphangiography
06

What researchers measure

Primary outcomes

  1. pattern of lymph drainage (Scale of 0 to 5)

    0(abnormal)-10(normal)

    Time frame: After magnetic resonance lymphangiography scans in up to 2years

  2. delay of lymph drainage (Scale of 0 to 10)

    0(delay)-10(normal)

    Time frame: After magnetic resonance lymphangiography scans in up to 2years

  3. depiction of lymph vessels (Scale of 0 to 10)

    0(Not clarity)-10(Clarity)

    Time frame: After magnetic resonance lymphangiography scans in up to 2years

  4. enhancement of inguinal lymph nodes (Scale of 0 to 10)

    0(Not clarity)-10(Clarity)

    Time frame: After magnetic resonance lymphangiography scans in up to 2years

  5. Visibility of Lymphatic Duct (Scale of 0 to 10)

    0(Invisible)-10(Clearly visible)

    Time frame: After magnetic resonance lymphangiography scans in up to 2years

07

Study locations

1 site
  • Seoul National University Hospital
    Seoul, Seoul 110-744, South Korea
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02550951
Responsible party
Seung Hong Choi (SeoulNUH, Seoul National University Hospital) — Principal investigator
First posted
Sep 16, 2015
Start date
Oct 2014
Primary completion
Oct 2016 (estimated)
Completion
Oct 2016 (estimated)
Last update
Sep 16, 2015

Study contacts

SeungHong Choi, MD,PhD
principal investigator · Seoul National University Hospital(Radiology)

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion